FIELD: chemistry.
SUBSTANCE: invention relates to novel lipopeptide compound of formula (I) 
, and to its pharmaceutically acceptable salts, where: R represents: 
and v represents integer number from 3 to 5. Invention also relates to based on the claimed compound pharmaceutical composition, which possesses antibacterial activity.
EFFECT: obtained is novel compound of formula (I), which can be applied in medicine in form of antibacterial medications against Clostridium difficile.
26 cl, 9 tbl, 20 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 0 |
|
SU490284A3 | |
| LIPOPEPTIDE PURIFICATION METHOD | 2010 |
|
RU2526391C2 |
| LOW-MOLECULAR DERIVATIVES OF PEPTIDES AS INHIBITORS OF LAMININ/NIDOGEN REACTION | 2000 |
|
RU2380371C2 |
| DERIVATIVES OF N-ACYL-α-AMINO ACID OR THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS, SIMPLE ETHERS OR ESTERS, AMIDES OR HYDRATES AND COMPOSITION INHIBITING ADHESIVE PROTEINS BINDING WITH PLATELETS AND PLATELET AGGREGATION | 1992 |
|
RU2097378C1 |
| METHOD OF TREATING SEPTIC SHOCK AND USING MURAMYL COMPOUNDS | 1992 |
|
RU2139086C1 |
| METHOD FOR IDENTIFICATION OF ANTI-TUMOR TARGET ENZYMES | 2002 |
|
RU2319482C2 |
| COMBINATIONS OF THERAPEUTIC AGENTS FOR CANCER TREATMENT | 2007 |
|
RU2449788C2 |
| COMBINATIONS CONTAININS Bcr-Abl/c-Kit/PDGF-RTK INHIBITORS FOR TREATING CANCER | 2007 |
|
RU2452492C2 |
| POLYPEPTIDE SHOWING IMMUNOMODULATING ACTIVITY | 1995 |
|
RU2091389C1 |
| IMPROVED PEPTIDE GASTRIN-RELEASING COMPOUNDS | 2003 |
|
RU2330859C2 |
